Results 81 to 90 of about 918,002 (207)

Novel endovascular management of a displaced aortic endograft component during transcatheter aortic valve replacement

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques
We report the case of a 73-year-old man with prior endovascular aneurysm repair (EVAR) of the abdominal aorta complicated by type Ia endoleak requiring two proximal aortic cuffs.
Punit Vyas, MD   +5 more
doaj   +1 more source

Vascular complications post-transcatheter aortic valve procedures

open access: yesIndian Heart Journal, 2016
Transcatheter aortic valve replacement (TAVR) has rapidly emerged as the standard of care for severe symptomatic aortic stenosis in patients whose comorbidities put them at prohibitive risk for surgical aortic valve replacement (SAVR).
Ashvarya Mangla, Saurabh Gupta
doaj   +1 more source

Long-term outlook for transcatheter aortic valve replacement [PDF]

open access: yes, 2017
Transcatheter aortic valve replacement (TAVR) revolutionized the treatment of severe symptomatic aortic stenosis (AS). TAVR is increasingly offered for lower-risk patients. The role and place of TAVR in the future treatment of AS is not clear yet.
Kappetein, A.P. (Arie Pieter)   +8 more
core   +1 more source

Aortic valve disease: Novel animal models for advancing our understanding of the underlying mechanisms

open access: yesAnimal Models and Experimental Medicine, Volume 9, Issue 10, Page 1964-1981, October 2026.
Due to the complex pathophysiology of aortic valve disease (AVD) and the resulting lack of effective pharmacotherapy, existing animal models are valuable research tools, but each has its own strengths and limitations. This review systematically surveys the major AVD models, compares their induction methods, pathological features, advantages and ...
Liya Hou   +4 more
wiley   +1 more source

Valve-in-valve-in homograft: A case of a repeat transcatheter aortic valve replacement in a patient with an aortic homograft

open access: yesAnnals of Cardiac Anaesthesia, 2016
In recent years, the use of transcatheter aortic valve replacement (TAVR) has extended beyond the treatment of native aortic valve stenosis in patients with high surgical risk.
Kimberly Naden Hollander   +2 more
doaj   +1 more source

Transcatheter aortic valve replacement

open access: yes, 2019
Transcatheter aortic valve replacement (TAVR) is indicated in some patients with severe aortic stenosis who are not candidates for surgery. This article explores when TAVR may be preferred over surgical aortic valve replacement and reviews perioperative ...
Karycki, Melody K.
core   +1 more source

Percutaneous Transaxillary Access for Large‐Bore Cardiovascular Interventions: Evidence, Technique, and Complication Management

open access: yesCatheterization and Cardiovascular Interventions, Volume 108, Issue 4, Page 1186-1197, October 1, 2026.
ABSTRACT Percutaneous transaxillary access is an established alternative to transfemoral large‐bore arterial access for transcatheter structural heart interventions and mechanical circulatory support (MCS). Although useful for overcoming hostile iliofemoral anatomy and providing prolonged support and patient mobilization in case of MCS, the axillary ...
Gioel Gabrio Secco   +9 more
wiley   +1 more source

Efficacy and Safety of Transcatheter vs. Surgical Aortic Valve Replacement in Low-to-Intermediate-Risk Patients: A Meta-Analysis

open access: yesFrontiers in Cardiovascular Medicine, 2020
Background: The efficacy and safety of transcatheter aortic-valve replacement (TAVR) vs. surgical aortic valve replacement (SAVR) for low- to intermediate-surgical risk patients remains uninvestigated.Objectives: We aimed to investigate the efficacy and ...
Yake Lou   +8 more
doaj   +1 more source

Validation of an Automated Artificial Intelligence‐Driven Planner for Transcatheter Aortic Valve Replacement

open access: yesCatheterization and Cardiovascular Interventions, Volume 108, Issue 4, Page 1473-1481, October 1, 2026.
ABSTRACT Background Preprocedural planning with multislice computed tomography (MSCT) is an essential prerequisite for successful transcatheter aortic valve replacement (TAVR). However, preprocedural planning is time‐consuming and may contain clinically meaningful interobserver variability.
Mark M. P. van den Dorpel   +11 more
wiley   +1 more source

Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients [PDF]

open access: yes, 2012
Transcatheter aortic valve replacement (TAVR) offers a new treatment option for patients with aortic stenosis, but costs may play a decisive role in decision making. Current studies are evaluating TAVR in an intermediate-risk population.
Head, Stuart J   +21 more
core   +1 more source

Home - About - Disclaimer - Privacy